{"brief_title": "Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST", "brief_summary": "The purpose of this study is to compare the effectiveness and safety of different doses of Niacin ER/Simvastatin (NS), in subjects with elevated fat levels in their blood (dyslipidemia).", "detailed_description": "The purpose of this study is to compare the efficacy and safety of different doses of Niacin ER/Simvastatin (NS), in subjects with elevated fat levels in their blood (dyslipidemia).", "condition": "Hypercholesterolemia", "intervention_type": "Drug", "intervention_name": "Niacin extended release and simvastatin tablets", "criteria": "Inclusion Criteria: - Patient has primary Type II hyperlipidemia or mixed dyslipidemia - If the patient is currently taking anti-dyslipidemic medications other than Zocor, he/she is willing to withdraw from these medications - Reasonable compliance with a standard cholesterol-lowering diet for a minimum of 4 weeks prior to screening and for the duration of the study. - LDL-C levels and/or Non HDL-C levels above normal for patients This study will be conducted both in the USA and internationally. Exclusion Criteria: - Patient has an allergy, hypersensitivity, or intolerance to niacin, statins, or their derivatives - HbA1c \u2265 9% in diabetic patients", "gender": "All", "minimum_age": "21 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00082251.xml"}